Metromile
-
“Tomorrow will be a better day.” “Next year will be a better year.” “The coming decade will be when this industry realizes its true potential.” We hear the same for most public enterprises.
-
The InsurTechs’ results show the path to profitability remains unclear, even as Lemonade said it expects to be self-funding from here.
-
The all-cash deal was completed following the closure of Metromile’s $500mn acquisition by Lemonade last week.
-
Last November, Lemonade struck a deal to buy the Californian InsurTech in an all-stock transaction, implying a diluted equity value of $500mn, or $200mn net of cash.
-
Metromile’s Preston and Lemonade co-CEOs Wininger and Schreiber all joined industry stalwarts in this year’s top 10.
-
The executive discussed InsurTech challenges, his priorities for Branch, fundraising, and his concerns about the capital markets.
-
Inside P&C’s morning summary of the key stories to get you up to speed fast.
-
Embedded insurance can help sidestep some of the challenges faced by InsurTech 1.0.
-
Inside P&C’s news team runs you through the key developments from the past week.
-
Following the announcement of the delay, Metromile shares rose over 9% earlier this morning to just under $0.90 per stock.
-
Inside P&C’s morning summary of the key stories to get you up to speed fast.
-
The companies have received approval from the Department of Justice under the Hart-Scott-Rodino Act and are awaiting other required regulatory approvals.
Related
-
Metromile posts $2.4mn contribution loss as loss ratio swells
February 28, 2022 -
Metromile shareholders approve Lemonade merger agreement
February 02, 2022